Current questions in soft tissue sarcoma: further steps with Yondelis®

Subtyping soft tissue sarcomas for treatment approaches

(2012) I. Judson et al.   ANNALS OF ONCOLOGY

New agents for the treatment of lymphoma

(2012) A. Stathis et al.   ANNALS OF ONCOLOGY

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

(2012) Winette TA van der Graaf et al.   LANCET

Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma

(2011) A. Gronchi et al.   ANNALS OF ONCOLOGY

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

(2011) Xavier García-del-Muro et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

(2009) George D. Demetri et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors

(2008) Wells A. Messersmith et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma

(2008) J.-Y. Blay et al.   CLINICAL CANCER RESEARCH